Ruflo, Jameberluke K.

HRN: 23-04-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/18/2023
05/25/2023
IVTT
730mg
Q8
URTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: